Showing results (31-40 of 87) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2015
Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based ChemotherapyUrsula Amstutz, Steven M Offer, Johanna Sistonen, et al.Journal of the National Cancer Center|July 22, 2024
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistanceZhiquan Wang, Rentian Wu, Qian Nie, et al.Supportive Cancer Therapy|July 18, 2008
Palmar-plantar erythrodysesthesia in patients receiving capecitabine and intratumor thymidine phosphorylase and dihydropyrimidine dehydrogenase: is there a pharmacologic explanation?Muhammad Wasif Saif, Vinni Juneja, Glenda Black, et al.Journal of Breath Research|March 10, 2011
(13)C-5-FU breath test current status and future directions: a comprehensive reviewHany H Ezzeldin, Edward P Acosta, Lori K Mattison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with CaucasiansLori Kay Mattison, Jeanne Fourie, Renee A Desmond, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|July 7, 2007
Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expressionXue Zhang, Richie Soong, Kangsheng Wang, et al.Mayo Clinic Proceedings|January 7, 2014
A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approachM Wasif Saif, Adam M Lee, Steven M Offer, et al.Pharmacogenetics and Genomics|January 25, 2008
Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolismHolly R Thomas, Hany H Ezzeldin, Vincenzo Guarcello, et al.Pharmacogenetics and Genomics|December 14, 2007
Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolismHolly R Thomas, Hany H Ezzeldin, Vincenzo Guarcello, et al.Clinical Pharmacology and Therapeutics|January 13, 2018
Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine DehydrogenaseShikshya Shrestha, Cheng Zhang, Calvin R Jerde, et al.Pageof 9